Acta Med. 2021, 64: 170-173

Chondroblastoma of the Temporal Bone: A Case Report and Literature Review

Katarína Obtulovičováa,*, Marián Sičáka, Adrian Kališb,c, Tomáš Budayd

aOtorinolaryngology/Head & Neck Surgery Clinic, the Central Military Hospital – Faculty Hospital, Ružomberok, Slovakia
bCatholic University in Ružomberok, Slovakia
cInstitute of Pathology, the Central Military Hospital – Faculty Hospital, Ružomberok, Slovakia
dThe Jessenius Medical Faculty of Comenius University in Martin, Slovakia

Received May 28, 2020
Accepted January 30, 2021

Introduction: Temporal bone chondroblastoma is a rare, locally aggressive tumour originating from immature cartilage, which recurs to a high degree. Treatment is surgical. Radiotherapy is reserved for recurrence. We describe a case of a 15-year-old-boy choosing a conservative surgical approach with reconstruction of the posterior canal wall. This study aims to report a rare pediatric case. Methods: A literature review was performed to better understand temporal bone chondroblastomas, to describe their histopathological and radiological characteristics and to establish the optimal surgical and non-surgical treatments. The research of previous published data was done using PubMed with keywords mentioned below. Results: Authors present a case of a 15-year-old boy with hearing impairment and facial nerve palsy. Conservative surgery with reconstruction of the tympanic membrane and posterior wall of the external auditory canal, restoring the hearing has been performed. We did not administer any adjuvant therapies. No sign of recurrence was observed 1 year after primary surgery. Facial nerve function is normal, and hearing is satisfactory. Conclusion: Chondroblastomas account for less than 1% of primary bone tumours. Temporal bone chondroblastoma is rare, locally aggressive, with a high prevalence of recurrence. This study describes specific histopathological and radiological findings, the chosen surgical approach and follow-up to improve the management and the prognosis of patients affected with this particular clinical entity.


10 live references